Skip to main content
. 2018 Nov 14;8:16798. doi: 10.1038/s41598-018-35009-y

Figure 5.

Figure 5

Representative platelet poor plasma (PPP) smears with added anti-E.coli LPS antibody and secondary antibody, from (A) healthy individuals, (B) Parkinson’s Disease (PD) individuals and (C) Type 2 Diabetes (T2D) individuals (1:200 dilution for primary and secondary antibodies).